FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2409004628> ?p ?o ?g. }

• W2409004628 endingPage "2157" @default.
• W2409004628 startingPage "2150" @default.
• W2409004628 abstract "To assess the long-term visual acuity results for intravitreal bevacizumab therapy in the treatment of subretinal neovascular membrane (SRNVM) secondary to idiopathic macular telangiectasia (Mactel) Type 2.This retrospective review of a consecutive, interventional case series includes patients with SRNVM secondary to Mactel Type 2 who were seen at Cincinnati Eye Institute from February 2006 to December 2014. Best-corrected visual acuity, fluorescein angiography, and optical coherence tomography measurements were performed. Exclusion criteria were the following: Mactel Type 2 patients without SRNVM, Mactel Type 1 patients, patients who had SRNVM or macular edema related to other maculopathies, and patients who had pars plana vitrectomy or laser treatment to the macula during the course of care or before their first visit.Twenty-five eyes of 20 patients with SRNVM secondary to Mactel Type 2 were included in the study. The mean baseline best-corrected visual acuity was 20/91 (median: 20/69) and the mean final best-corrected visual acuity was 20/62 (median: 20/60) at the last visit (P < 0.0001). The mean number of injections was 8.4 ± 11.1 (range: 2-53, median: 4). The mean pretreatment central macular thickness of 254 μm improved to 205 μm at the final visit (P = 0.011). No complications related to intravitreal bevacizumab injection were noted during the mean follow-up time of 40.8 ± 33.7 months (range: 4-108 months, median: 24 months).Intravitreal bevacizumab therapy is an effective long-term treatment modality for SRNVM secondary to Mactel Type 2 based on improvement in best-corrected visual acuity and associated reduction in central macular thickness." @default.
• W2409004628 created "2016-06-24" @default.
• W2409004628 creator A5016039997 @default.
• W2409004628 creator A5017671015 @default.
• W2409004628 creator A5073635631 @default.
• W2409004628 creator A5087401353 @default.
• W2409004628 date "2016-11-01" @default.
• W2409004628 modified "2023-09-26" @default.
• W2409004628 title "LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2" @default.
• W2409004628 cites W1487328877 @default.
• W2409004628 cites W1967274554 @default.
• W2409004628 cites W1976557886 @default.
• W2409004628 cites W1979047354 @default.
• W2409004628 cites W1980805958 @default.
• W2409004628 cites W1993856821 @default.
• W2409004628 cites W1994975972 @default.
• W2409004628 cites W1995443671 @default.
• W2409004628 cites W1997402685 @default.
• W2409004628 cites W2003992884 @default.
• W2409004628 cites W2008455201 @default.
• W2409004628 cites W2015033282 @default.
• W2409004628 cites W2017149756 @default.
• W2409004628 cites W2026747391 @default.
• W2409004628 cites W2027108246 @default.
• W2409004628 cites W2042596027 @default.
• W2409004628 cites W2042680968 @default.
• W2409004628 cites W2048332276 @default.
• W2409004628 cites W2052188656 @default.
• W2409004628 cites W2053327646 @default.
• W2409004628 cites W2068416568 @default.
• W2409004628 cites W2071529795 @default.
• W2409004628 cites W2075198919 @default.
• W2409004628 cites W2075984382 @default.
• W2409004628 cites W2076691603 @default.
• W2409004628 cites W2078595806 @default.
• W2409004628 cites W2086763399 @default.
• W2409004628 cites W2104525395 @default.
• W2409004628 cites W2122668687 @default.
• W2409004628 cites W2316758803 @default.
• W2409004628 cites W2318615007 @default.
• W2409004628 cites W2332771055 @default.
• W2409004628 cites W4294255520 @default.
• W2409004628 doi "https://doi.org/10.1097/iae.0000000000001035" @default.
• W2409004628 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27258671" @default.
• W2409004628 hasPublicationYear "2016" @default.
• W2409004628 type Work @default.
• W2409004628 sameAs 2409004628 @default.
• W2409004628 citedByCount "15" @default.
• W2409004628 countsByYear W24090046282017 @default.
• W2409004628 countsByYear W24090046282018 @default.
• W2409004628 countsByYear W24090046282019 @default.
• W2409004628 countsByYear W24090046282020 @default.
• W2409004628 countsByYear W24090046282021 @default.
• W2409004628 countsByYear W24090046282022 @default.
• W2409004628 crossrefType "journal-article" @default.
• W2409004628 hasAuthorship W2409004628A5016039997 @default.
• W2409004628 hasAuthorship W2409004628A5017671015 @default.
• W2409004628 hasAuthorship W2409004628A5073635631 @default.
• W2409004628 hasAuthorship W2409004628A5087401353 @default.
• W2409004628 hasConcept C118487528 @default.
• W2409004628 hasConcept C141071460 @default.
• W2409004628 hasConcept C2776694085 @default.
• W2409004628 hasConcept C2777063560 @default.
• W2409004628 hasConcept C2777802072 @default.
• W2409004628 hasConcept C2778075232 @default.
• W2409004628 hasConcept C2778257484 @default.
• W2409004628 hasConcept C2780248432 @default.
• W2409004628 hasConcept C2780699112 @default.
• W2409004628 hasConcept C2781100027 @default.
• W2409004628 hasConcept C2781242345 @default.
• W2409004628 hasConcept C2781359195 @default.
• W2409004628 hasConcept C71924100 @default.
• W2409004628 hasConceptScore W2409004628C118487528 @default.
• W2409004628 hasConceptScore W2409004628C141071460 @default.
• W2409004628 hasConceptScore W2409004628C2776694085 @default.
• W2409004628 hasConceptScore W2409004628C2777063560 @default.
• W2409004628 hasConceptScore W2409004628C2777802072 @default.
• W2409004628 hasConceptScore W2409004628C2778075232 @default.
• W2409004628 hasConceptScore W2409004628C2778257484 @default.
• W2409004628 hasConceptScore W2409004628C2780248432 @default.
• W2409004628 hasConceptScore W2409004628C2780699112 @default.
• W2409004628 hasConceptScore W2409004628C2781100027 @default.
• W2409004628 hasConceptScore W2409004628C2781242345 @default.
• W2409004628 hasConceptScore W2409004628C2781359195 @default.
• W2409004628 hasConceptScore W2409004628C71924100 @default.
• W2409004628 hasIssue "11" @default.
• W2409004628 hasLocation W24090046281 @default.
• W2409004628 hasLocation W24090046282 @default.
• W2409004628 hasOpenAccess W2409004628 @default.
• W2409004628 hasPrimaryLocation W24090046281 @default.
• W2409004628 hasRelatedWork W1999244126 @default.
• W2409004628 hasRelatedWork W2037939016 @default.
• W2409004628 hasRelatedWork W2078285148 @default.
• W2409004628 hasRelatedWork W2121621777 @default.
• W2409004628 hasRelatedWork W2146225974 @default.
• W2409004628 hasRelatedWork W2326535627 @default.
• W2409004628 hasRelatedWork W2409004628 @default.
• W2409004628 hasRelatedWork W2583068534 @default.

• next